4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-006524
CHIEF EXECUTIVE OFFICER sold 40,000 shares at an average $46.91 ($1,876,353)
- CHIEF EXECUTIVE OFFICER acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-03-03 | Option exercise 10b5-1 | +40,000 | $2.94 | $117,440 | 155,920 | D |
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-03-03 | Sale 10b5-1 | −19,392 | $46.61 | $903,861 | 136,528 | D |
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-03-03 | Sale 10b5-1 | −20,608 | $47.19 | $972,492 | 115,920 | D |
| Derivatives | |||||||
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-03-03 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −40,000 | 238,487 | D | ||
| Open-market sales · 40,000 sh · avg $46.91 · $1,876,353 | |||||||
Loading xslF345X05/form4-03042025_090312.xml…